COVID-19 Therapeutic Alert

Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19

In parallel to the publication of revised guidance from the National Institute for Health and Care Excellence (NICE), the previously published UK interim position statement covering inhaled budesonide as a treatment option for individuals with COVID infection has been withdrawn.

Inhaled budesonide should no longer be considered as a treatment for COVID-19 infection other than within the context of a clinical trial. People already using budesonide for conditions other than COVID-19 should continue treatment if they test positive for COVID-19.

Further information and actions can be found in the alert.

Spread the cost of your membership

With the recent cost of living rises, we’re all making savings wherever we can – and you can do the same with your RPS membership.

Instead of paying for everything all at once, make life easier by paying monthly. After all, you use your RPS membership benefits all year round, so it makes sense to pay for them the same way.

With monthly Direct Debit, you only have a small, regular payment each month. It’s the easy way to keep practicing at your best, without making a hole in your finances!

Spread the cost of your membership - join by monthly Direct Debit today.

Support Alert

Spread the cost of your membership